RAN biotechnologies
Cambridge, United States· Est. 2019
Develops RNA-based therapeutics and delivery technologies for treating cancer and other diseases.
Private Company
Total funding raised: $14.5M
About
Develops RNA-based therapeutics and delivery technologies for treating cancer and other diseases.
RNA TherapeuticsOncology
Funding History
2Total raised:$14.5M
Series A$12MJun 15, 2020
Seed$2.5MJun 15, 2018